The 1990 Headline That Wouldn't Die, and What the Data Actually Shows

In 1990, a study published in a major medical journal reported that growth hormone injections had reversed the equivalent of ten to twenty years of aging in a group of older men over six months. It made global headlines and, in many ways, launched the modern anti-aging HGH narrative that persists today. The problem is that the underlying science never fully supported the claim, and decades of subsequent research have made that clear.

Growth hormone is naturally released by the pituitary in discrete pulses, concentrated mostly during deep sleep. Injected HGH doesn't replicate that pattern — it produces a flat, constant level in circulation, a meaningfully different physiological state from the body's own pulsatile release, and part of why its effects and side-effect profile differ from natural GH activity.

Most of what GH actually does happens indirectly. It signals the liver to produce IGF-1, and IGF-1 does much of the downstream work of driving growth and metabolic effects, before eventually feeding back to reduce further GH release — a self-regulating loop under normal physiology, though one that exogenous GH partially overrides.

The most reliable evidence available today comes from a meta-analysis pooling 18 trials in healthy older adults. The findings were considerably more modest than the 1990 headline suggested: roughly a couple of kilograms less fat and a similar amount more lean mass, but no measurable improvement in strength or physical function, and researchers noted some of the apparent lean mass gain was likely water retention rather than muscle tissue.

The honest distinction that's often lost in casual conversation: GH is legitimate, well-established medicine for people with a diagnosed deficiency. For healthy adults seeking anti-aging benefits, its use is off-label, not supported by strong evidence of functional benefit, and in the United States it's actually illegal to distribute HGH specifically for anti-aging purposes.

The side effects trace directly back to the mechanism — water retention, carpal tunnel syndrome, joint pain, and elevated blood sugar are all consistent with excess GH signaling. The long-term cautionary example is acromegaly, the disease that results from chronic GH excess, which illustrates what sustained overexposure to the hormone actually looks like.

Why this matters for tracking: if HGH or GH-adjacent compounds are part of your regimen or curiosity, IGF-1, fasting glucose, and body composition (not just scale weight) are the markers that will tell you the real story — far more reliably than the decades-old headline that started this whole conversation.